Paris-based En Carta secures €1.5 million pre-seed to advance platform for early Lyme disease detection

Published on May 22, 2024

En Carta Diagnostics, a deeptech startup developing rapid Point-of-Care (POC) molecular diagnostics kits, announced €1.5 million in pre-seed funding. This investment will enable En Carta to make a substantial leap forward in achieving preclinical data on a prototype diagnostic kit for its flagship indication, the debilitating Lyme disease, while ensuring its ability to scale industrially. …

This content is for members only. Visit the site and log in/register to read.

The post Paris-based En Carta secures €1.5 million pre-seed to advance platform for early Lyme disease detection appeared first on EU-Startups.

Continue reading on website
Other news

Oyo, once valued at $10 billion, shelves IPO plans for second time

May 22, 2024
India's Oyo, once valued at $10 billion, has withdrawn its IPO application from the market regulator for the second time.© 2024 TechCrunch. All rights reserved. For personal use only.

EU Sparks for climate: Citizen hackathon championship begins

May 22, 2024
The EU Sparks for Climate: Citizen Hackathon Championship is calling on citizens and researchers to tackle urgent climate challenges. This virtual competition aims to develop innovative solutions and supports two key EU missions: Climate Change Adaptation and Climate-Neutral and Smart Cities. From May to June 2024, 22 virtual local hackathons will be held, engaging teams… This content is for membe